Pirtobrutinib Prior to CAR T Therapy
Pirtobrutinib Prior to Bispecific Anti-CD20/CD19 CAR T-Cell Therapy in Patients With Relapsed/Refractory Lymphoma

Released: June 05, 2024

Expiration: June 04, 2025

Activity

Progress
1
Course Completed